Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 8248175, 14 pages
https://doi.org/10.1155/2017/8248175
Research Article

Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation

1Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA, USA
2Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA
3Department of Obstetrics and Gynecology, Morehouse School of Medicine, Atlanta, GA, USA
4Department of Community Health & Preventive Medicine, Morehouse School of Medicine, Atlanta, GA, USA

Correspondence should be addressed to Ruben Rene Gonzalez-Perez; ude.msm@zelaznogr

Received 12 January 2017; Accepted 27 April 2017; Published 4 June 2017

Academic Editor: Eric A. Singer

Copyright © 2017 Danielle Daley-Brown et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Danielle Daley-Brown, Gabriela Oprea-Iles, Kiara T. Vann, et al., “Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation,” Disease Markers, vol. 2017, Article ID 8248175, 14 pages, 2017. https://doi.org/10.1155/2017/8248175.